| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |